Cite
Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
MLA
Jin, Kairui, et al. “Hypofractionated Radiotherapy with Simultaneous Tumor Bed Boost (Hi-RISE) in Breast Cancer Patients Receiving Upfront Breast-Conserving Surgery: Study Protocol for a Phase III Randomized Controlled Trial.” Radiation Oncology, vol. 19, no. 1, May 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13014-024-02449-y.
APA
Jin, K., Luo, J., Yu, X., & Guo, X. (2024). Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial. Radiation Oncology, 19(1), 1–9. https://doi.org/10.1186/s13014-024-02449-y
Chicago
Jin, Kairui, Jurui Luo, Xiaoli Yu, and Xiaomao Guo. 2024. “Hypofractionated Radiotherapy with Simultaneous Tumor Bed Boost (Hi-RISE) in Breast Cancer Patients Receiving Upfront Breast-Conserving Surgery: Study Protocol for a Phase III Randomized Controlled Trial.” Radiation Oncology 19 (1): 1–9. doi:10.1186/s13014-024-02449-y.